249 related articles for article (PubMed ID: 23722456)
1. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
[TBL] [Abstract][Full Text] [Related]
2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
6. Transitory effect on endolymphatic hydrops of the intratympanic steroids for Ménière's disease.
Martin-Sanz E; Esteban-Sanchez J; Rodrigañez-Riesco L; Sanz-Fernández R
Laryngoscope; 2015 May; 125(5):1183-8. PubMed ID: 25429741
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
9. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
Weckel A; Marx M; Esteve-Fraysse MJ
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
[TBL] [Abstract][Full Text] [Related]
10. The use of electrocochleography to monitor the response of Ménière's disease patients to intratympanic steroids.
Martin-Sanz E; Luzardo CZ; Riesco LR; Patino TM; Sanz R
Acta Otolaryngol; 2013 Nov; 133(11):1158-64. PubMed ID: 24125187
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic steroid injections for intractable Ménière's disease.
Barrs DM; Keyser JS; Stallworth C; McElveen JT
Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
Nedzelski JM; Chiong CM; Fradet G; Schessel DA; Bryce GE; Pfleiderer AG
Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière's disease.
Lambert PR; Nguyen S; Maxwell KS; Tucci DL; Lustig LR; Fletcher M; Bear M; Lebel C
Otol Neurotol; 2012 Sep; 33(7):1257-65. PubMed ID: 22858715
[TBL] [Abstract][Full Text] [Related]
14. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
Shea PF; Richey PA; Wan JY; Stevens SR
Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic gentamicin therapy for Ménière's disease.
Hirsch BE; Kamerer DB
Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
Beyea JA; Instrum RS; Agrawal SK; Parnes LS
Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
19. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
Öztürk K; Ata N
Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
